New CAR-T dawn for autoimmune disease: lupus case fuels research and investment
TL;DR Summary
Five years after a lupus patient achieved lasting remission with CAR-T therapy, the case has stirred broad pharma interest and spurred ongoing research into CAR-T for autoimmune diseases, offering renewed hope while highlighting challenges ahead.
- 5 years after lupus breakthrough, CAR-T is still surprising autoimmunity researchers statnews.com
- Woman With 3 Autoimmune Diseases Enters Remission After Immune 'Reset' ScienceAlert
- A new trick for old science, and biotech VCs’ scrambled playbook statnews.com
- Scientists Are Finally Unlocking a Cancer Treatment’s Full Potential The Atlantic
- Woman with three deadly diseases has ‘remarkable’ recovery after cell therapy The Guardian
Reading Insights
Total Reads
0
Unique Readers
5
Time Saved
2 min
vs 3 min read
Condensed
93%
497 → 35 words
Want the full story? Read the original article
Read on statnews.com